NCT07295600

Brief Summary

The goal of this clinical trial is to evaluate changes in glucose and lipid levels after consuming challenge meals enriched with selected indigenous fruits and vegetables in people living with type 2 diabetes in Wakiso district. The main question to answer is: Does the consumption of challenge meals enriched with indigenous fruits and vegetables improve glucose and lipid levels among people living with type 2 diabetes? Researchers will compare the effects of different challenge meals on glucose and lipid levels to identify the indigenous fruit and vegetable with the strongest glucose- and lipid-lowering effects. Participants will: Consume five challenge meals over 5 weeks. Visit the study site after a 5-7 day rest period to consume the challenge meal and complete the tests.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
3mo left

Started May 2026

Shorter than P25 for not_applicable type-2-diabetes

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

May 13, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

December 3, 2025

Last Update Submit

April 30, 2026

Conditions

Keywords

Type 2 diabetesChallenge mealsPostprandialGlucose metabolismIndigenous fruits and Vegetables

Outcome Measures

Primary Outcomes (1)

  • Incremental area under the curve blood glucose

    Blood glucose analysis for blood samples collected at 8 different time points:0, 15, 30, 60, 90, 120, 150 and 180 minutes

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

Secondary Outcomes (6)

  • Incremental area under the curve blood triglyceride

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

  • Incremental area under the curve high density lipoprotein cholestrol (HDL)

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

  • Incremental area under the curve low density lipoprotein cholestrol (LDL)

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

  • Incremental area under the curve total cholestrol

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

  • Incremental area under the curve plasma polyphenol metabolites

    From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks

  • +1 more secondary outcomes

Other Outcomes (3)

  • Body mass Index (BMI)

    BMI will be calculated only on day one of the study that lasts five weeks

  • Fat mass

    Fat mass will be calculated only on day one of the study that lasts five weeks

  • Waist circumference

    Waist circumference will be calculated only on day one of the study that lasts five weeks

Study Arms (5)

Challenge meal enriched with Hibiscus sabdariffa (Hibiscus)

EXPERIMENTAL
Other: Indigenous Fruit and vegetable.

Challenge meal enriched with Solunum anguivi (Forest bitter berries)

EXPERIMENTAL
Other: Indigenous Fruit and vegetable.

Challenge meal enriched withTamarindus indica (Tamarind)

EXPERIMENTAL
Other: Indigenous Fruit and vegetable.

Reference meal one

ACTIVE COMPARATOR
Other: Challenge meal that resembles the oral glucose tolerance test.

Reference meal two

ACTIVE COMPARATOR
Other: Challenge meal that resembles the oral glucose tolerance test.

Interventions

Indigenous fruit and vegetable freeze dried powder.

Challenge meal enriched with Hibiscus sabdariffa (Hibiscus)Challenge meal enriched with Solunum anguivi (Forest bitter berries)Challenge meal enriched withTamarindus indica (Tamarind)

Isocaloric challenge meal

Reference meal oneReference meal two

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Fasting blood sugar \>= \[7 mmol/L\](based on medical records)
  • Diabetic regimen for at least 6 months
  • Type 2 diabetes
  • Plans to continue staying in the same location for the next 6 months

You may not qualify if:

  • Taking dietary supplements
  • Type 1 diabetes
  • Tuberculosis co-infection
  • Renal failure
  • Liver cirrhosis
  • Chronic pancreatitis
  • Pregnancy and Lactation
  • Regular sports activity
  • Parallel participation in another clinical trial
  • On treatment for dyslipidaemia,
  • On treatment for hypertension
  • Very low blood pressure (\< 90/50 mmHg)
  • Allergic reactions to test products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Vegetables

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Christophe Matthys, Phd

    KU Leuven University, Belgium

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Proffessor

Study Record Dates

First Submitted

December 3, 2025

First Posted

December 19, 2025

Study Start (Estimated)

May 13, 2026

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

May 6, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Individual Participant Data (IPD) Sharing Statement Plan to Share IPD: Plan Description: All the data generated during this study will comply with the prevailing standards and guidelines in documenting and depositing data sets. The results from this research will be disseminated in presentations at public lectures, scientific institutions and meetings, and/or publication in reputable journals. Data sharing will be performed in compliance with the International Committee of Medical Journal Editors. Individual de-identified participant data will be shared. In particular, individual participant data that underlie the results reported in our articles, after de-identification (text, tables, figures and appendices). Supporting Materials: Study Protocol Informed Consent Form (ICF) Analytic Code Time Frame: Data will become available from 9-36 months after the publication of the study results by the research team. Access Criteria: Data will only be shared with investigators

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
9 to 18 months after article publication.